Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence

The Kidney Disease: Improving Global Outcomes (KDIGO) 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (CKD) represents a focused update of the KDIGO 2020 guideline on the topic. The guideline targets a broad audience of clinicians treating people with diabetes and...

Full description

Saved in:
Bibliographic Details
Published in:Kidney international Vol. 102; no. 5; p. 990
Main Authors: Rossing, Peter, Caramori, M Luiza, Chan, Juliana C N, Heerspink, Hiddo J L, Hurst, Clint, Khunti, Kamlesh, Liew, Adrian, Michos, Erin D, Navaneethan, Sankar D, Olowu, Wasiu A, Sadusky, Tami, Tandon, Nikhil, Tuttle, Katherine R, Wanner, Christoph, Wilkens, Katy G, Zoungas, Sophia, Craig, Jonathan C, Tunnicliffe, David J, Tonelli, Marcello A, Cheung, Michael, Earley, Amy, de Boer, Ian H
Format: Journal Article
Language:English
Published: United States 01.11.2022
Subjects:
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - diagnosis
Diabetes Mellitus, Type 2 - therapy
Glucose
Humans
Renal Insufficiency, Chronic - complications
Renal Insufficiency, Chronic - diagnosis
Renal Insufficiency, Chronic - therapy
dialysis
glycemic monitoring
chronic kidney disease
team-based care
metformin
mineralocorticoid receptor antagonist
systematic review
SGLT2 inhibitor
self-management
renin–angiotensin system
lifestyle
glycemic targets
nutrition
models of care
angiotensin-converting enzyme inhibitor
angiotensin II receptor blocker
guideline
KDIGO
glycemia
hemodialysis
GLP-1 receptor agonist
HbA1c
evidence-based
ISSN:1523-1755, 1523-1755
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Kidney Disease: Improving Global Outcomes (KDIGO) 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (CKD) represents a focused update of the KDIGO 2020 guideline on the topic. The guideline targets a broad audience of clinicians treating people with diabetes and CKD. Topic areas for which recommendations are updated based on new evidence include Chapter 1: Comprehensive care in patients with diabetes and CKD and Chapter 4: Glucose-lowering therapies in patients with type 2 diabetes (T2D) and CKD. The content of previous chapters on Glycemic monitoring and targets in patients with diabetes and CKD (Chapter 2), Lifestyle interventions in patients with diabetes and CKD (Chapter 3), and Approaches to management of patients with diabetes and CKD (Chapter 5) has been deemed current and was not changed. This guideline update was developed according to an explicit process of evidence review and appraisal. Treatment approaches and guideline recommendations are based on systematic reviews of relevant studies and appraisal of the quality of the evidence, and the strength of recommendations followed the "Grading of Recommendations Assessment, Development and Evaluation" (GRADE) approach. Limitations of the evidence are discussed, and areas for which additional research is needed are presented.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Instructional Material/Guideline-2
ObjectType-Feature-3
content type line 23
ISSN:1523-1755
1523-1755
DOI:10.1016/j.kint.2022.06.013